A New Generation of Malaria Vaccines
Miriam Bergeret, MSc | September4th,2020
Promising results from the first in-human trials of genetically engineered malaria vaccines
Miriam Bergeret, MSc
Miriam Bergeret is a freelance writer based in Toronto. She obtained her MSc in laboratory medicine and pathobiology from the University of Toronto and is a strong advocate of rare disease research.
Articles by Miriam Bergeret, MSc
Microbiome Profiling Could Improve Early Pancreatic Cancer Diagnosis
Miriam Bergeret, MSc | September1st,2020
Recent research reveals a complex interaction between the microbiome and the immune system in pancreatic cancer
Could Procalcitonin Tests Reduce Antibiotic Use in COVID-19?
Miriam Bergeret, MSc | August20th,2020
Recent evidence suggests procalcitonin tests may be able to identify COVID-19 patients with bacterial coinfections to guide antibiotic treatment
Tumor Organoids for Functional Precision Oncology
Miriam Bergeret, MSc | July15th,2020
Researchers are using patient-derived tumor organoids to match patients with optimal treatments
How NGS is Making Personalized Cancer Vaccines a Reality
Miriam Bergeret, MSc | July9th,2020
Next-generation sequencing has revolutionized the detection of tumor neoantigens
A New Generation of Malaria Vaccines
Miriam Bergeret, MSc | June16th,2020
Promising results from the first in-human trials of genetically engineered malaria vaccines
A Step Toward Standardized Residual Disease Testing in Acute Myeloid Leukemia
Miriam Bergeret, MSc | May6th,2020
Minimal residual disease is a powerful prognostic factor, but expert says it’s not yet an exact science
Flow Cytometry Reveals Immune System Dysregulation in Coronavirus Patients
Miriam Bergeret, MSc | April22nd,2020
How multiparameter flow cytometry can give a rapid picture of a patient’s immune response from a single blood sample